NYSEArca - Delayed Quote USD

SPDR S&P Biotech ETF (XBI)

91.18 -1.41 (-1.52%)
At close: May 17 at 4:00 PM EDT
91.21 +0.03 (+0.03%)
After hours: May 17 at 7:58 PM EDT
Loading Chart for XBI
DELL
  • Previous Close 92.59
  • Open 92.52
  • Bid 91.21 x 2200
  • Ask 91.29 x 1200
  • Day's Range 90.85 - 93.05
  • 52 Week Range 63.80 - 103.52
  • Volume 7,247,023
  • Avg. Volume 11,338,209
  • Net Assets 6.36B
  • NAV 91.10
  • PE Ratio (TTM) --
  • Yield 0.02%
  • YTD Daily Total Return 2.12%
  • Beta (5Y Monthly) 0.95
  • Expense Ratio (net) 0.35%

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

SPDR State Street Global Advisors

Fund Family

Health

Fund Category

6.36B

Net Assets

2006-01-31

Inception Date

Performance Overview: XBI

Trailing returns as of 5/17/2024. Category is Health.

YTD Return

XBI
2.12%
Category
0.45%
 

1-Year Return

XBI
6.37%
Category
1.63%
 

3-Year Return

XBI
10.36%
Category
3.64%
 

People Also Watch

Holdings: XBI

Top 10 Holdings (12.90% of Total Assets)

SymbolCompany% Assets
ALPN
Alpine Immune Sciences, Inc. 1.88%
RVMD
Revolution Medicines, Inc. 1.32%
IBRX
ImmunityBio, Inc. 1.30%
VKTX
Viking Therapeutics, Inc. 1.26%
MRNA
Moderna, Inc. 1.22%
EXEL
Exelixis, Inc. 1.20%
NTRA
Natera, Inc. 1.19%
CRNX
Crinetics Pharmaceuticals, Inc. 1.18%
CERE
Cerevel Therapeutics Holdings, Inc. 1.18%
GERN
Geron Corporation 1.18%

Sector Weightings

SectorXBI
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: XBI

Research Reports: XBI

Related Tickers